KALAMAZOO - The Michigan Medical Device Summit Sept. 20 in Kalamazoo is the annual gathering of the statewide medtech community. It is designed for attendees to learn about the latest in medical device technologies, regulations and marketplace, and especially what Michigan’s cluster has to offer to those developing and manufacturing innovative medical products. Hear the
LIVONIA — Hygieia, a provider of digital therapeutics for insulin management, has added Metro Detroit Endocrinology Center in Dearborn as a clinical partner. The partnership extends Hygieia’s d-Nav network and makes autonomous insulin therapy service available for underserved populations. The unique d-Nav Insulin Management Program uses AI-powered technology to prescribe the appropriate insulin dose each
GRAND RAPIDS – Michigan-based companies HealthBar and BAMF Health announced their partnership in which they will be providing concierge healthcare services to patients who travel to BAMF’s Grand Rapids location for their treatment. The partnership will provide “white glove” nursing services for patients around their care schedules including transportation to and from appointments. BAMF Health
LIVONIA – Hygieia, a digital therapeutics company for insulin therapy, has appointed Doug Lawrence its chief executive officer, responsible for leading operations, development, and global growth of the company and its d-Nav Insulin Management Program. Lawrence brings three decades of medical technology leadership to his new role at Hygieia, including significant experience bringing products to
FLINT --XLerateHealth, a healthcare accelerator headquartered in Louisville, KY, on Tuesday announced the selection of eight startup companies to participate in its 2022 Flint cohort. XLH Flint has received support from the Charles Stewart Mott Foundation, the Community Foundation of Flint and the City of Flint. “This is an exciting cohort for Flint - each
DETROIT - Recently, a tiny group of people with rectal cancer saw their disease vanish after experimental treatment. It was a very small trial done by doctors at New York's Memorial Sloan Kettering Cancer Center, wherein the patients took a drug called dostarlimab for six months. At the end of their trial, every single one of their
NEW YORK - In what appears to be a very promising breakthrough for the treatment of rectal cancer, a small drug trial conducted in the US found every patient treated in the experiment had their cancer successfully go into remission. The medication given, called dostarlimab and sold under the brand name Jemperli, is an immunotherapy drug used
LANSING - As millions of U.S. employees voluntarily resign and employers desperately scramble to find workers, a new survey suggests employee health strategy may be a key ingredient to keeping employees well and at work. Among employees thinking about changing jobs, better benefits in general (38 percent), better healthcare benefits specifically (36 percent), as well
GRAND RAPIDS - Grand Valley's College of Health Professions has partnered with Samaritas Senior Living of Grand Rapids to develop an immersive program where students will interact with seniors on a daily basis. This pilot program, launching in fall of 2022, will give two College of Health Professions (CHP) students an opportunity to live and
GRAND RAPIDS - Grand Valley State University received $1 million in federal appropriations to expand its applied Medical Device Institute (aMDI) and provide new technologies that will better serve the medical innovation industry while expanding West Michigan's economic footprint. U.S. Rep. Peter Meijer, (R-Mich.), requested and received this funding, which was packaged into the 2022
